Trulicity market share?

I can help with that. To give accurate market-share numbers, I need a couple of specifics:

- Region: US only or global?
- Timeframe: latest full year (e.g., 2023 or 2024), trailing 12 months, or a specific quarter?
- Metric: market share by sales/revenue, by prescription volume, or by patient numbers?

If you want, I can pull the most recent figures from sources like IQVIA, Statista, or company annual reports and summarize them.

High-level context (without numbers):
- Trulicity (dulaglutide) is a top GLP-1 receptor agonist and has long been a leading product in the class.
- In many markets, Ozempic (semaglutide) has the largest share of the GLP-1 class, with Trulicity typically ranking second or among the top three.
- Shares can vary by region and year, influenced by new launches (e.g., oral semaglutide) and shifts in prescribing.
- Market-share figures can differ depending on whether you look at revenue, prescriptions, or patient counts.

Tell me your preferred region and metric, and I’ll fetch the latest numbers and summarize them for you.